<DOC>
	<DOCNO>NCT02262546</DOCNO>
	<brief_summary>The objective study assess pramipexole prolong QT interval placebo</brief_summary>
	<brief_title>Influence Pramipexole QT Interval ECG Healthy Male Female Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Pramipexole</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>All participant study need healthy male females 21 50 year age Body mass index ( BMI ) range 18.5 29.9 kg/m2 Signed write informed consent prior admission study accordance Good Clinical Practice local legislation Any finding medical examination ( include blood pressure , pulse rate ECG ) deviate normal clinical relevance Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder History orthostatic hypotension , faint spell blackouts Chronic relevant acute infection History allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Intake drug long halflife ( &gt; 24 hour ) within least one month less ten halflives respective drug enrolment study study Use drug might influence result trial 7 day prior enrolment study study Participation another trial investigational drug ( ≤ 30 day prior administration trial ) Heavy smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Inability refrain smoke trial day Alcohol abuse ( &gt; 60 g/day ) Drug abuse Blood donation ( ≥ 100 mL within four week prior administration trial ) Any deviation laboratory value consider clinical relevance Excessive physical activity within last week trial trial Hypersensitivity pramipexole , moxifloxacin and/or relate drug class Supine blood pressure screen systolic &lt; 100 mmHg diastolic &lt; 60 mmHg Heart rate screen &gt; 80 beat per minute ( bpm ) &lt; 40 bpm Any screen ECG value outside reference range clinical relevance include , limited Pulse Rate interval &gt; 220 m , QRS interval &gt; 115 m , QTcB QTcF &gt; 450 m , QT ( uncorrected ) &gt; 470 ms Subjects involve passenger transport operation dangerous machine For Female Subjects : Pregnancy Positive pregnancy test No adequate contraception ( adequate contraception : e.g . sterilization , intrauterine device , oral contraceptive ) Inability maintain adequate contraception whole study period Lactation period</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>